Skip to main content

Table 2 Sample Informations of GSE32960 Training Set and Validation Set

From: Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma

Clinical Features

GSE32960(train)

GSE36682(test)

P

OS

   

  0

117

121

0.6897

  1

39

35

Metastatic

   

  NO

122

124

0.8897

  YES

34

32

Relapse

   

  NO

132

136

0.6256

  YES

24

20

T Stage

   

  T1

30

36

0.7632

  T2

48

41

  T3

36

35

  T4

42

44

N Stage

   

  N0

23

21

0.7131

  N1

73

75

  N2

39

33

  N3

21

27

Stage

   

  I

5

7

0.8443

  II

45

41

  III

47

44

  IV

59

64

Gender

   

  Male

119

114

0.6025

  Female

37

42

Age

   

  ≤ 45

78

70

0.2474

  >45

78

86

EBV

   

  YES

150

149

1

  NO

6

7

Radiotherapy interupt

   

  NO

90

88

0.9089

  YES

66

68

Radiotherapy boosting

   

  NO

85

78

0.4965

  YES

71

78

Cocurrent chemotherapy

   

  NO

26

18

0.2549

  YES

130

138